You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pozelimab

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

Available
  • Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Aug 31, 2023

CD55-Deficient Protein-Losing Enteropathy Trial (Pozelimab)

Available
  • CD55-Deficient Protein-Losing Enteropathy
  • Pozelimab
  • (no location specified)
Aug 14, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Feb 22, 2023

CD55-deficient Protein-losing Enteropathy, CHAPLE Trial in Bethesda, Pathum Wan, Istanbul (Pozelimab)

Active, not recruiting
  • CD55-deficient Protein-losing Enteropathy
  • CHAPLE
  • Pozelimab
  • Bethesda, Maryland
  • +2 more
Nov 8, 2022

Healthy Trial in London (Pozelimab, Cemdisiran)

Completed
  • Healthy
  • London, United Kingdom
    Regeneron Research Site
Jul 1, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Leeds (Pozelimab, Cemdisiran)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Leeds, United Kingdom
    Regeneron Study Site
Apr 13, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Ravulizumab, Pozelimab, Cemdisiran)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Whittier, California
  • +8 more
Nov 29, 2022

Paroxysmal Nocturnal Hemoglobinuria (PNH), CD55-deficient Protein-losing Enteropathy (PLE), CD59 Deficiency Trial (Pozelimab)

Available
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • +2 more
  • Pozelimab
  • (no location specified)
Jan 28, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Cemdisiran, Eculizumab, Pozelimab)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Whittier, California
    Regeneron Research Facility
Jan 28, 2022

Healthy Trial in Antwerp (Pozelimab, Cemdisiran)

Completed
  • Healthy
  • Antwerp, Belgium
    Regeneron Research Site
Nov 11, 2021

Generalized Myasthenia Gravis Trial in Worldwide (Pozelimab + Cemdisiran, Cemdisiran, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • Pozelimab + Cemdisiran
  • +3 more
  • Phoenix, Arizona
  • +46 more
Jan 31, 2023

Healthy Volunteer Trial in Antwerpen (Pozelimab)

Completed
  • Healthy Volunteer
  • Pozelimab
  • Antwerpen, Belgium
    Regeneron Study Site
Mar 19, 2021